EXPD
45
2
ABBV
60
-4
JCI
55
11
AAL
18
-2
BIIB
38
-2
APD
40
-2
FITB
53
-2
LB
48
4
FOXA
63
-3
BMY
43
-5
HON
57
3
CHD
54
-2
HST
32
3
GT
32
-4
LLY
48
-3
CMG
51
4
M
23
6
EA
49
2
L
58
2
LUV
50
-2
EXPD
45
2
ABBV
60
-4
JCI
55
11
AAL
18
-2
BIIB
38
-2
APD
40
-2
FITB
53
-2
LB
48
4
FOXA
63
-3
BMY
43
-5
HON
57
3
CHD
54
-2
HST
32
3
GT
32
-4
LLY
48
-3
CMG
51
4
M
23
6
EA
49
2
L
58
2
LUV
50
-2
Financhill
Back

Trevi Therapeutics Stock Price Chart

AI Marketing Shift Is Happening–Act Before It's Too Late!

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Buy
63

TRVI
Trevi Therapeutics

Last Price:
$6.15
Seasonality Move:
25.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Apple's Drop in iPhone Sales Opens the Door for New Entrant

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
  • The current trend is moderately bullish and TRVI is experiencing slight buying pressure.

Trevi Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 6.41 Sell
20-day SMA: 6.04 Sell
50-day SMA: 4.9 Buy
200-day SMA: 3.56 Buy
8-day EMA: 6.33 Sell
20-day EMA: 6.01 Buy
50-day EMA: 5.2 Buy
200-day EMA: 3.84 Buy

Trevi Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.45 Buy
Relative Strength Index (14 RSI): 54.03 Buy
Chaikin Money Flow: 661193 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.73 - 6.73) Buy
Bollinger Bands (100): (2.97 - 5.33) Buy

Trevi Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Trevi Therapeutics Stock

Is Trevi Therapeutics Stock a Buy?

TRVI Technical Analysis vs Fundamental Analysis

Buy
63
Trevi Therapeutics (TRVI) is a Buy

Is Trevi Therapeutics a Buy or a Sell?

Trevi Therapeutics Stock Info

Market Cap:
581.1M
Price in USD:
6.01
Share Volume:
2.7M

Trevi Therapeutics 52-Week Range

52-Week High:
7.39
52-Week Low:
2.30
Buy
63
Trevi Therapeutics (TRVI) is a Buy

Trevi Therapeutics Share Price Forecast

Is Trevi Therapeutics Stock a Buy?

  • Trevi Therapeutics share price is 6.01 while TRVI 8-day exponential moving average is 6.33, which is a Sell signal.
  • The stock price of TRVI is 6.01 while Trevi Therapeutics 20-day EMA is 6.01, which makes it a Buy.
  • Trevi Therapeutics 50-day exponential moving average is 5.20 while TRVI share price is 6.01, making it a Buy technically.
  • TRVI stock price is 6.01 and Trevi Therapeutics 200-day simple moving average is 3.84, creating a Buy signal.

Fundamental Analysis of Trevi Therapeutics

Is Trevi Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.04 per share.

Technical Analysis of Trevi Therapeutics

Should I short Trevi Therapeutics stock?

* Trevi Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.